Human heat shock protein 70 peptide complexes specifically activate antimelanoma t cells

Cancer Research

Volumn 61, Issue 1, 2001, Pages 222-227

  Castelli, C ^a   Ciupitu, A T ^a   Rini, F ^a   Rivoltini, L ^a   Mazzocchi, A ^a   Kiessling, R ^a   Parmiani, G ^a  

^a NATIONAL CANCER INSTITUTE   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

CANCER VACCINE; CHAPERONE; DIFFERENTIATION ANTIGEN; GAMMA INTERFERON; HEAT SHOCK PROTEIN 70; HLA ANTIGEN CLASS 1;

ANTIGEN PRESENTING CELL; ANTIGEN RECOGNITION; ARTICLE; CELLULAR DISTRIBUTION; CONTROLLED STUDY; CYTOKINE RELEASE; HUMAN; HUMAN CELL; MELANOMA CELL; PRIORITY JOURNAL; T LYMPHOCYTE; T LYMPHOCYTE ACTIVATION; TUMOR IMMUNITY;

ANTIGEN-PRESENTING CELLS; ANTIGENS, NEOPLASM; CROSS REACTIONS; EPITOPES, T-LYMPHOCYTE; HISTOCOMPATIBILITY ANTIGENS CLASS I; HLA ANTIGENS; HSP70 HEAT-SHOCK PROTEINS; HUMANS; LYMPHOCYTE ACTIVATION; MELANOMA; MOLECULAR CHAPERONES; T-LYMPHOCYTES; T-LYMPHOCYTES, CYTOTOXIC;

EID: 0035132104     PISSN: 00085472     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (23)

1. A new era for cancer immunotherapy based on the genes that encode cancer antigens
2. Tumor regressions observed in patients with metastatic melanoma treated with an antigenic peptide encoded by gene MAGE-3 and presented by HLA-AL
3. Tumor immunity as autoimmunity: Tumor antigens include normal self proteins which stimulate anergic peripheral T cells
4. Tumor immunogenicity is determined by the mechanism of cell death via induction of heat shock protein expression
5. Consequences of cell death. Exposure to necrotic tumor cells, but not primary tissue cells or apoptotic cells, induces the maturation of immunostimulatory dendritic cells
6. Heat shock proteins come of age: Primitive functions acquire new roles in an adaptive world
7. Protein translocation: Is HSP70 pulling my chain
8. Protein translocation: How HSP pulls it off
9. Stress proteins and immunity mediated by cytotoxic T lymphocytes
10. A mechanism for the specific immunogenicity of heat shock protein-chaperoned peptides
11. Immunotherapy of tumors with autologous tumor-derived heat shock protein
12. T-cell recognition of melanoma-associated antigens
13. Novel HLA-Cw8-restricted T-cell epitopes derived from TRP-2 and gp100 melanoma antigens
14. Immunogenicity of the ALLAVGATK (gp100[17-25]) peptide in HLA-A3.1 melanoma patients
15. Identification of the immunodominant peptides of the MART-1 human melanoma antigen recognized by the majority of HLA-A2-restricted tumor infiltrating lymphocytes
16. Purification of immunogenic heat shock protein 70-peptide complexes by ADP-affinity chromatography
17. Immunization with a LCMV peptide mixed with heat shock protein 70 results in protective anti-viral immunity and specific CTLs
18. Common and divergent peptide binding specificities of hsp70 molecular chaperones
19. Rapid extracellular degradation of synthetic class I peptides by human dendritic cells
20. Cross-priming of minorhistocompatibility antigen specific cytotoxic T cells upon immunization with the heat-shock protein gp96
21. Isolation of MHC class I-restricted tumor antigen peptide and its precursors associated with heat shock proteins HSP70, HSP90, and gp96
22. HSP70 stimulate cytokine production though a CD14-dependent pathway, demonstrating its dual role as a chaperone and cytokine
23. In vivo and in vitro activation of T cells after administration of antigen-negative heat shock proteins